Accounting for Aetiology: Can Regional Surveillance Data Alongside Host Biomarker-Guided Antibiotic Therapy Improve Treatment of Febrile Illness in Remote Settings?

Wellcome Open Research - United Kingdom
doi 10.12688/wellcomeopenres.14976.2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Biomarker-Guided Antibiotic Therapy in Adult Critically Ill Patients: A Critical Review

Annals of Intensive Care
Critical CareIntensive Care Medicine
2012English

Scrub Typhus – An Overlooked Aetiology for Acute Febrile Illness in Bangladesh: A Case Report

BIRDEM Medical Journal
2019English

A Provincial Acute Febrile Illness Surveillance Network (GAFINet), South Korea

Online Journal of Public Health Informatics
2018English

Can We Use a Biomarker to Guide Antibiotic Treatment in Severe COPD Exacerbations?

Breathe
PulmonaryRespiratory Medicine
2019English

Biomarker Guided Therapy in Chronic Heart Failure

Cardiac Failure Review
2015English

Response To: 'Data From UK Biobank on Febrile Illness'

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2016English

Can Institutional Investors’ Participation Improve Accounting Conservatism in China?

European Scientific Journal ESJ
2019English

Host Biomarkers for Distinguishing Bacterial From Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review

PLoS ONE
Multidisciplinary
2016English

Treatment of Urinary Tract Infections Among Febrile Young Children With Daily Intravenous Antibiotic Therapy at a Day Treatment Center

Pediatrics
Child HealthPediatricsPerinatology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy